Arch Therapeutics Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • ARTH
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.10
  • (As of Friday Closing)

Arch Therapeutics General Information

Description

Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
PINX
Primary Office
  • 235 Walnut Street
  • Suite 6
  • Framingham, MA 01702
  • United States
+1 (617) 000-0000

Arch Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arch Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.10 $0.10 $0.09 - $0.23 $22.7M 237M 439K -$0.02

Arch Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019 FY 2018 30-Sep-2018
EV 29,355 32,158 38,477 62,516
Revenue 10 0 0 0
EBITDA (5,241) (4,684) (4,539) (4,809)
Net Income (5,245) (4,691) (4,548) (4,814)
Total Assets 6,853 2,151 2,902 4,840
Total Debt 1,776 726 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arch Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arch Therapeutics‘s full profile, request access.

Request a free trial

Arch Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Terrence Norchi MD Co-Founder, Chief Executive Officer, President & Chairman
Richard Davis Chief Financial Officer
Michael Abrams Chief Financial Officer
Rutledge Ellis-Behnke Ph.D Vice President, R&D Engineering and Quality Systems
Chirag Shah Ph.D Vice President, Research and Development Engineering and Quality Systems
You’re viewing 5 of 11 executive team members. Get the full list »

Arch Therapeutics Board Members (4)

Name Representing Role Since
Avtar Dhillon MD Self Chairman 000 0000
Terrence Norchi MD Arch Therapeutics Co-Founder, Chief Executive Officer, President & Chairman 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Arch Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arch Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Arch Therapeutics‘s full profile, request access.

Request a free trial

Arch Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 05-Jun-2013 000000000000000000 00.00 Internet Retail
To view Arch Therapeutics’s complete acquisitions history, request access »